98 related articles for article (PubMed ID: 27606346)
1. Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site.
Roda RH; FitzGibbon EJ; Boucekkine H; Schindler AB; Blackstone C
Ann Clin Transl Neurol; 2016 Aug; 3(8):650-4. PubMed ID: 27606346
[TBL] [Abstract][Full Text] [Related]
2. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
[TBL] [Abstract][Full Text] [Related]
3. Novel
Santos M; Damásio J; Kun-Rodrigues C; Barbot C; Sequeiros J; Brás J; Alonso I; Guerreiro R
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32340215
[TBL] [Abstract][Full Text] [Related]
4. Sialic Acid Is Required for Neuronal Inhibition by Soluble MAG but not for Membrane Bound MAG.
Al-Bashir N; Mellado W; Filbin MT
Front Mol Neurosci; 2016; 9():21. PubMed ID: 27065798
[TBL] [Abstract][Full Text] [Related]
5. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.
Pan B; Fromholt SE; Hess EJ; Crawford TO; Griffin JW; Sheikh KA; Schnaar RL
Exp Neurol; 2005 Sep; 195(1):208-17. PubMed ID: 15953602
[TBL] [Abstract][Full Text] [Related]
6. Pelizaeus-Merzbacher-Like Disease in a Family With Variable Phenotype and a Novel Splicing GJC2 Mutation.
Al-Yahyaee SA; Al-Kindi M; Jonghe PD; Al-Asmi A; Al-Futaisi A; Vriendt ED; Deconinck T; Chand P
J Child Neurol; 2013 Nov; 28(11):1467-1473. PubMed ID: 23143715
[TBL] [Abstract][Full Text] [Related]
7. Pelizaeus-Merzbacher disease, easily misdiagnosed as cerebral palsy: a report of a three-generation family.
Chen YC; Liang WC; Su YN; Jong YJ
Pediatr Neonatol; 2014 Apr; 55(2):150-3. PubMed ID: 23597542
[TBL] [Abstract][Full Text] [Related]
8. Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides.
Sun J; Shaper NL; Itonori S; Heffer-Lauc M; Sheikh KA; Schnaar RL
Glycobiology; 2004 Sep; 14(9):851-7. PubMed ID: 15175257
[TBL] [Abstract][Full Text] [Related]
9. Hypomyelinating leukodystrophy associated with a deleterious mutation in the ATRN gene.
Shahrour MA; Ashhab M; Edvardson S; Gur M; Abu-Libdeh B; Elpeleg O
Neurogenetics; 2017 Jul; 18(3):135-139. PubMed ID: 28493104
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
[TBL] [Abstract][Full Text] [Related]
11. Anti-MAG associated cerebellar ataxia and response to rituximab.
Zis P; Rao DG; Hoggard N; Sarrigiannis PG; Hadjivassiliou M
J Neurol; 2018 Jan; 265(1):115-118. PubMed ID: 29159464
[TBL] [Abstract][Full Text] [Related]
12. Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein.
Sakamoto Y; Shimizu T; Tobisawa S; Isozaki E
Neurol Sci; 2017 Dec; 38(12):2165-2169. PubMed ID: 28980134
[TBL] [Abstract][Full Text] [Related]
13. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
Hudson LD
J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
[TBL] [Abstract][Full Text] [Related]
14. A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C>A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene.
Seeman P; Paderova K; Benes V; Sistermans EA
Int J Mol Med; 2002 Feb; 9(2):125-9. PubMed ID: 11786921
[TBL] [Abstract][Full Text] [Related]
15. [Anti-MAG paraproteinemic demyelinating polyneuropathy: a clinical, biological, electrophysiological and anatomopathological descriptive study of a 13-patients' cohort].
Launay M; Delmont E; Benaim C; Sacconi S; Butori C; Desnuelle C
Rev Neurol (Paris); 2009 Dec; 165(12):1071-9. PubMed ID: 19487003
[TBL] [Abstract][Full Text] [Related]
16. Myelin associated glycoprotein modulates glia-axon contact in vivo.
Li C; Trapp B; Ludwin S; Peterson A; Roder J
J Neurosci Res; 1998 Jan; 51(2):210-7. PubMed ID: 9469574
[TBL] [Abstract][Full Text] [Related]
17. Examination of the biological role of the alpha(2-->6)-linked sialic acid in gangliosides binding to the myelin-associated glycoprotein (MAG).
Schwardt O; Gäthje H; Vedani A; Mesch S; Gao GP; Spreafico M; von Orelli J; Kelm S; Ernst B
J Med Chem; 2009 Feb; 52(4):989-1004. PubMed ID: 19175312
[TBL] [Abstract][Full Text] [Related]
18. Soluble myelin-associated glycoprotein released from damaged white matter inhibits axonal regeneration.
Tang S; Qiu J; Nikulina E; Filbin MT
Mol Cell Neurosci; 2001 Sep; 18(3):259-69. PubMed ID: 11591127
[TBL] [Abstract][Full Text] [Related]
19. [Humoral antibodies in immune mediated neuropathy].
Saito T
Rinsho Shinkeigaku; 1990 Dec; 30(12):1364-7. PubMed ID: 1966017
[TBL] [Abstract][Full Text] [Related]
20. Nerve ultrasound findings in neuropathy associated with anti-myelin-associated glycoprotein antibodies.
Lucchetta M; Padua L; Granata G; Luigetti M; Campagnolo M; Dalla Torre C; Coraci D; Sabatelli M; Briani C
Eur J Neurol; 2015 Jan; 22(1):193-202. PubMed ID: 25174585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
